PMC/PubMed Indexed Articles
Indexed In
- Academic Journals Database
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Scimago
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- MIAR
- University Grants Commission
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 22, which means every article in Journal of Vaccines & Vaccination has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
59 | 65 | 71 | 11 | 19 |
Year wise citations received |
174 | 249 | 218 | 197 | 194 |
| Journal total citations count | 2051 |
| Journal Impact Factor | 2.87 |
| Journal 5 years Impact Factor | 3.73 |
| Journal CiteScore | 4.69 |
| Journal h-index | 22 |
Important citations
Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and
Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis
Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries.
Immunogenicity and safety of a tetravalent dengue vaccine during a five-year follow-up period
Systematic review of dengue vaccine efficacy
Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial.
Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study.
Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials.
Tackling dengue fever: Current status and challenges
A recombinant live attenuated tetravalent vaccine for the prevention of dengue.
Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).
Clinical Efficacy, Safety, and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (CYD-TDV) in Children: A Systematic Review with Meta-analysis.
Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials.
Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety.
Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.
Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil